Thrivent Financial for Lutherans Acquires Shares of 175,865 VanEck Pharmaceutical ETF (NASDAQ:PPH)

Thrivent Financial for Lutherans acquired a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 175,865 shares of the company’s stock, valued at approximately $16,088,000. Thrivent Financial for Lutherans owned about 2.61% of VanEck Pharmaceutical ETF as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. Optimum Investment Advisors bought a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth about $27,000. GPS Wealth Strategies Group LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth about $42,000. CWM LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth about $55,000. International Assets Investment Management LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 2nd quarter worth about $86,000. Finally, Comerica Bank lifted its holdings in shares of VanEck Pharmaceutical ETF by 39.4% in the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after acquiring an additional 378 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Down 0.1 %

VanEck Pharmaceutical ETF stock opened at $96.00 on Wednesday. The firm has a 50-day moving average price of $95.68 and a 200-day moving average price of $91.85. The firm has a market capitalization of $647.04 million, a PE ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12-month low of $74.05 and a 12-month high of $99.51.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, July 5th. Stockholders of record on Monday, July 1st were issued a $0.3558 dividend. The ex-dividend date was Monday, July 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.